Whatbђ ™ moreover, many patients said they

Vancouver BЂ "implanted microchip that releases the drug by a team of wireless signals has been demonstrated in people for the first time using a drug to treat osteoporosis. This tiny device implanted under the skin may be useful in treating many diseases that require to take medication regularly, the researchers reported Feb. 16 at the annual meeting of the American Association for the Advancement of Science. BЂњThis reveals profound possibilities for improving the treatment and possible telemedicine BЂ, "said Robert Farra, president of microchips Inc, a company funded and conducted part of the study. The document describes the results were published online Feb. 16 in

Science Translational Medicine by employees of the chips, MIT, Harvard University and Case Western Reserve. The idea behind the microchip, which may release chemicals in the body at a particular time has been developed by scientists at the Massachusetts Institute of Technology a decade ago. But researchers need to make sure drugs are well stored in the device. In addition, the immune system tends to create a barrier around collagen implanted devices, which could complicate the drug to make it into the bloodstream. In the new study, individual unit doses of the drug teriparatide sealed inside was implanted under the waist of the eight women suffering from osteoporosis. When the microprocessor deviceBЂ ™ and receives a wireless signal, a current passes through a microchip, break a metal layer containing one dose of the drug. Approximately two months after the device was implanted BЂ "followed by a protective barrier of the immune systemBЂ ™ s created BЂ" wireless signals to set the device to release daily doses of teriparatide. Drug that increases bone mass, usually by injection. Based on blood tests, a dose of the device appeared to raise the level of molecule, called P1NP, indicating that bone building BЂ "evidence that teriparatide released from the microchip works as expected. However, there are technical limitations with this device. John Watson, bioengineering researcher at the University of California, San Diego, said that the sequence of these devices is a problem. One device didnBЂ ™ t produce any lasix 40 mg ivp drug in one of the first patients. No side effects appeared in one of the study participants, Farra said. WhatBЂ ™ Moreover, many patients said they werenBЂ ™ t worried about the device, or was, in fact, forget about it. Found in:. I